BIRC5 and posterior cortical atrophy: On the other hand, while survivin was previously identified as a relevant target in advanced PCa, our work provides a more comprehensive and clinically integrated perspective by correlating survivin expression with real-world treatment responses to platinum in mCRPC patients.